xalkori 250 mg hard capsules
pfizer limited - crizotinib - hard capsules - 250 mg - carcinoma, non-small-cell lung - anti-neoplastic agents, protein kinase inhibitor - indicated for the treatment of adults with previously treated anaplastic lymphoma kinase (alk)-positive advanced non-small cell lung cancer (nsclc)
terazosin accord 2mg tablets
accord healthcare limited - terazosin - tablet - terazosin 2 mg - urologicals
terazosin accord 5mg tablets
accord healthcare limited - terazosin - tablet - terazosin 5 mg - urologicals
ibuprofen 200 mg film-coated tablets
accord healthcare limited - ibuprofen - film-coated tablet - 200 milligram(s) - propionic acid derivatives; ibuprofen
ibuprofen 400 mg film-coated tablets
accord healthcare limited - ibuprofen - film-coated tablet - 400 milligram(s) - propionic acid derivatives; ibuprofen
ibuprofen 600 mg film-coated tablets
accord healthcare limited - ibuprofen - film-coated tablet - 600 milligram(s) - propionic acid derivatives; ibuprofen
tadalafil
accord healthcare limited - tadalafil - film coated tablet - 5 milligram - tadalafil
tadalafil 10mg film-coated tablets
accord healthcare limited - tadalafil - film-coated tablet - 10 milligram(s) - drugs used in erectile dysfunction; tadalafil
tadalafil 20 mg film-coated tablets
accord healthcare limited - tadalafil - film-coated tablet - 20 milligram(s) - drugs used in erectile dysfunction; tadalafil
terazosin 5mg tablets
ltt pharma limited - terazosin - tablet - 5 milligram(s) - alpha-adrenoreceptor antagonists; terazosin